Urinary Soluble VCAM-1 is a Useful Biomarker of Disease Activity and Treatment Response in Lupus Nephritis

Autor: Pedro Guilherme Schaefer, Odirlei André Monticielo, Marina Siebert, Andrese Aline Gasparin, Nicole Pamplona Bueno de Andrade, Vanessa Hax, Francisco José Veríssimo Veronese, Penelope Esther Palominos, Romulo Marx
Rok vydání: 2020
Předmět:
Zdroj: BMC Rheumatology, Vol 4, Iss 1, Pp 1-10 (2020)
BMC Rheumatology
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
DOI: 10.21203/rs.3.rs-35503/v1
Popis: Introduction Vascular cell adhesion molecule-1 (VCAM-1) is involved in the progression of glomerular and tubulointerstitial injury in lupus nephritis (LN) and can be easily assessed in urine. The aim of this study was to assess urinary soluble VCAM-1 (uVCAM-1) as a biomarker of disease activity and treatment response in LN. Methods This prospective study enrolled 62 patients with class III, IV or V LN diagnosed within the last 3 years and divided them in two groups: with and without active nephritis at the inclusion, each group with 31 patients. At each visit, a urine sample was collected for uVCAM-1 evaluation and the nephritis status was assessed. Results Median uVCAM-1 level was elevated in patients with active compared to inactive LN (P P P = 0.002) and did not change in patients who remained inactive (P = 0.797). The level of uVCAM-1 peaked during the flare of LN (P Conclusion The uVCAM-1 is a reliable biomarker that reflects renal disease activity and is useful for monitoring individual patients with lupus nephritis over time.
Databáze: OpenAIRE